Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Formato:	Artigo
Idioma:	Inglês
Publicado:	Karger Publishers 2012-02-01
Series:	Case Reports in Oncology
Assuntos:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
Acceso en liña:	http://www.karger.com/Article/FullText/337022
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!